Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR

Haematologica

Volumn 94, Issue 11, 2009, Pages 1595-1598

  Quintanilla Martinez, Leticia ^a   Slotta Huspenina, Julia ^b   Koch, Ina ^b   Klier, Margit ^a   Hsi, Eric D ^c   De Leval, Laurence ^d   Klapper, Wolfram ^e   Gesk, Stefan ^e   Siebert, Reiner ^e   Fend, Falko ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

Cyclin D2+; FISH; Mantle cell lymphoma (MCL); QRT PCR

Indexed keywords

CYCLIN D2; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; LYMPHOID TISSUE; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; REAL TIME POLYMERASE CHAIN REACTION;

AGED; CYCLIN D2; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSLOCATION, GENETIC;

EID: 70449435187     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.010173     Document Type: Article

References (14)

1. Jares P, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007;7:750-762 (Pubitemid 47463673)
2. Rosenwald A, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-197 (Pubitemid 37443390)
3. Fu K, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, et al. Lymphoma/Leukemia Molecular Profiling Project. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005;106:4315-4321
4. Gesk S, Martín-Subero JI, Nagel I, Harder L, Fu K, Bernd HW, et al. A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006;108:1109-1110 (Pubitemid 44154656)
5. Wlodarska I, Vanhentenrijk V, Van Roosbroeck K, Pospísilová H, Minnei F, Verhoef G, et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008;12:5683-5690
6. Herens C, Lambert F, Quintanilla- Martinez L, Bisig B, Deusings C, de Leval L. Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14) (p13;q32) and cyclin D2 overexpression. Blood 2008;111:1745-1746 (Pubitemid 351213474)
7. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Editors. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
8. Quintanilla-Martinez L, Davies-Hill T, Fend F, Calzada-Wack J, Sorbara L, Campo E, et al. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood 2003;101:3181-3187 (Pubitemid 36858013)
9. Koch I, Slotta-Huspenina J, Hollweck R, Anastasov N, Hofler H, Quintanilla- Martinez L, Fend F. Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues. Diagn Mol Pathol 2006;15:149-156 (Pubitemid 44325476)
10. Specht K, Kremer M, Müller U, Dirnhofer S, Rosemann M, Höfler H, et al. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription- PCR of microdissected paraffin sections. Clin Cancer Res 2002;8: 2902-2911 (Pubitemid 35025738)
11. Quintanilla-Martinez L, Miething C, Klier M, Rudelius M, Davies-Hill T, Anastasov N, et al. NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein β in ALK-positive anaplastic large cell lymphoma. Blood 2006;108:2029-2036 (Pubitemid 44395017)
12. Klier M, Anastasov N, Hermann A, Meindl T, Angermeier D, Raffeld M, et al. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia 2008;11:2097-2105
13. Slotta-Huspenina J, Koch I, Richter M, Bink K, Kremer M, Specht K, et al. Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions. Leuk Res 2008;32:79-88. (Pubitemid 350100855)
14. Specht K, Haralambieva E, Bink K, Kremer M, Mandl-Weber S, Koch I, et al. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 2004;104:1120-1126 (Pubitemid 39038033)